Literature DB >> 17496550

Late introduction of sirolimus induces anemia in renal transplant recipients.

Olivier Thaunat, Carole Beaumont, Sophie Lechaton, Henri Kreis, Emmanuel Morelon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17496550     DOI： 10.1097/01.tp.0000260424.75005.c1

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  4 in total

1.  Mammalian target of rapamycin (mTOR) inhibitors: potential uses and a review of haematological adverse effects.

Authors:  Sofia Sofroniadou; David Goldsmith
Journal:  Drug Saf       Date:  2011-02-01       Impact factor: 5.606

Review 2.  Laboratory use of hepcidin in renal transplant recipients.

Authors:  Lucija Šimetić; Lada Zibar
Journal:  Biochem Med (Zagreb)       Date:  2016       Impact factor: 2.313

3.  Profiling sirolimus-induced inflammatory syndrome: a prospective tricentric observational study.

Authors:  Fanny Buron; Paolo Malvezzi; Emmanuel Villar; Cécile Chauvet; Bénédicte Janbon; Laure Denis; Maria Brunet; Sameh Daoud; Rémi Cahen; Claire Pouteil-Noble; Marie-Claude Gagnieu; Jacques Bienvenu; François Bayle; Emmanuel Morelon; Olivier Thaunat
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

4.  mTOR Inhibitors Induce Erythropoietin Resistance in Renal Transplant Recipients.

Authors:  Reece Jefferies; Harish Puttagunta; Anoushka Krishnan; Ashley Irish; Ramyasuda Swaminathan; John K Olynyk
Journal:  Front Med (Lausanne)       Date:  2022-02-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.